Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport
Open Access
- 1 May 2011
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 52 (5), 951-957
- https://doi.org/10.1194/jlr.m011122
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Myeloid Differentiation Primary Response Protein 88 Couples Reverse Cholesterol Transport to InflammationCell Metabolism, 2010
- Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2Journal of Lipid Research, 2010
- The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosisJournal of Lipid Research, 2009
- Management of cardiovascular disease risk in chronic inflammatory disordersNature Reviews Rheumatology, 2009
- Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors*Journal of Lipid Research, 2008
- Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivoJCI Insight, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Localization of Nitration and Chlorination Sites on Apolipoprotein A-I Catalyzed by Myeloperoxidase in Human Atheroma and Associated Oxidative Impairment in ABCA1-dependent Cholesterol Efflux from MacrophagesPublished by Elsevier BV ,2005
- Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW CellsInfection and Immunity, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001